4
Total investments
1
Early stage
1
Mid stage
2
Late stage
17y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Apr 2024
Meet Kneevoice, pioneering new way to diagnose by utilizing neural-networks for sound and vibrations capturing analysis.
Kneevoice has developed a digital patellofemoral audio-arthrography system, combining a high-tech sound acquisition system with revolutionary cloud-based machine-learned algorithms, to promptly and efficiently achieve diagnostic accuracy previously available only through nondynamic, nonspecific, or invasive tests.
Two devices rely on the Kneevoice platform:
- A wired device to be used at Medical, Physical Therapy, and Team Sports locations
- A Wireless Wearable device to be used by individuals to prevent cartilage damage, monitor after-intervention progress, and/or excel at sports and fitness programs
Kneevoice will become the diagnostic pathway of choice for patellofemoral diagnosis, interventional monitoring, as well as health and wellness of the knee in the general population, tapping and capturing a share in the $15 billion US market, with an accurate, patient and physician-friendly solution that significantly prevents joint damage and reduce healthcare costs.
Board Observer
Apr 2023
Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.
Board Observer
May 2020
Introducing allergens easily and safely for your baby.
Our system is simple: a pre-measured, allergist-developed daily packet that mixes in with breast milk, formula, or babys first solid food, containing the top 9 most common childhood food allergies, including peanut, egg, milk, almond, cashew, walnut, soy, wheat, and sesame. 100% organic, non-GMO, and no sugar added.
Co-Founder and Board Member
Jun 2009
As the premier service focused on leveraged loan amendments, LendAmend is where amendments come together℠.
LendAmend.com is a web-based platform developed for professionals in the leveraged loan market to streamline the amendment process and provide administrative support to participants in the $1 trillion leveraged loan market.
Our solutions provide members with electronic signature page release, compliance monitorning capabilities/reports, real-time vote count data, and a centralized network to facilitate the execution of leveraged loan amendments.
Registered members include CLO managers, banks, hedge funds, insurance companies, asset managers, mutual funds, and other institutional investors in the syndicated bank loan market.
Experience · 9 entries
All (9)
Investments (3)
Founder (1)
Board (3)
2024
Board Observer
Apr 2024
Meet Kneevoice, pioneering new way to diagnose by utilizing neural-networks for sound and vibrations capturing analysis.
Kneevoice has developed a digital patellofemoral audio-arthrography system, combining a high-tech sound acquisition system with revolutionary cloud-based machine-learned algorithms, to promptly and efficiently achieve diagnostic accuracy previously available only through nondynamic, nonspecific, or invasive tests.
Two devices rely on the Kneevoice platform:
- A wired device to be used at Medical, Physical Therapy, and Team Sports locations
- A Wireless Wearable device to be used by individuals to prevent cartilage damage, monitor after-intervention progress, and/or excel at sports and fitness programs
Kneevoice will become the diagnostic pathway of choice for patellofemoral diagnosis, interventional monitoring, as well as health and wellness of the knee in the general population, tapping and capturing a share in the $15 billion US market, with an accurate, patient and physician-friendly solution that significantly prevents joint damage and reduce healthcare costs.
2023
Board Observer
Apr 2023
Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.
2020
Board Observer
May 2020
Introducing allergens easily and safely for your baby.
Our system is simple: a pre-measured, allergist-developed daily packet that mixes in with breast milk, formula, or babys first solid food, containing the top 9 most common childhood food allergies, including peanut, egg, milk, almond, cashew, walnut, soy, wheat, and sesame. 100% organic, non-GMO, and no sugar added.
F
Managing Director and Head of Analytics
Mar 2020
FinDox is a next-generation workflow management and data solution for financial professionals.
FinDox is a streamlined, smarter way to aggregate confidential documents, automate restricted lists, review issuer information and manage regulatory reporting. We provide clean data, reporting and document controls in one central place.
FinDox is a privately held, well funded, secure and modern technology provider. Our clients include the majority of the Top-50 CLO managers, the leading alternative asset management firms of the world, emerging credit managers, hedge funds, distressed funds, banks and private credit managers.
2017
A
AGT Ventures
Principal
Jan 2017
Show all 9 entries ↓
Investment activity
2009–2024 · 4 investments
Recent (last 2 years)Earlier
